Case Study: An Institutional GLP-1 Research Program Cutting Peptide Cost by 28% with a Supply Contract
Customer Stories | 2026-07-09 | 7 min read
A de-identified case study of an institutional GLP-1 research program reducing peptide procurement cost by 28% and eliminating grant-delays through a 12-month supply contract with tier pricing and monthly auto-release.
Background: two NIH grants, one fragmented supply chain
An academic research group with two active NIH-funded grants studying GLP-1 agonists in obesity was spending approximately USD 220,000 per year on peptides across tirzepatide, semaglutide, and five supporting metabolic compounds. The procurement workflow was manual, fragmented, and expensive: three catalog suppliers, no volume commitment, no forecast, and 3-4 hours per week of the lab manager's time spent on peptide ordering.
Both grants had milestone timelines that peptide procurement was threatening to delay. A procurement system upgrade was identified as a high-ROI investment.
The challenge: three procurement inefficiencies
Inefficiency 1: No volume leverage All three suppliers were selling at catalog list price because the program had never committed to a volume forecast. The program was buying 200+ vials per year across 7 compounds but had never leveraged that volume to negotiate pricing.
Inefficiency 2: Manual ordering workflow Every peptide order required the lab manager to check each supplier's website, place the order manually, track shipment, verify COA on receipt, and file documentation. At 3-4 hours per week, this was 150-200 hours per year — equivalent to one month of a research assistant's time.
Inefficiency 3: No quality agreement There was no quality agreement with any supplier. COA quality varied. When a lot failed acceptance, there was no defined process for resolution, replacement, or credit.
The solution: a 12-month supply contract with auto-release
Step 1: Procurement audit (3 weeks)
- 12 months of PO data analyzed by compound, supplier, and monthly spend
- Top 5 compounds identified: tirzepatide, semaglutide, and three supporting peptides
- Manual ordering time quantified: 180 hours per year
Step 2: RFQ and contract negotiation (4 weeks)
- RFQ sent to four B2B peptide suppliers with a 12-month forecast
- Two suppliers returned tier-priced quotes; ZePeptide selected based on COA quality, lead time, and cold-chain validation
- Supply contract signed: 12-month commitment, monthly auto-release of top 5 SKUs, Net 30 terms
Step 3: Auto-release launch (3 weeks)
- Monthly auto-release schedule set: 15 vials tirzepatide, 20 vials semaglutide, 10 vials each of three supporting peptides
- On-call release available for the remaining 2 compounds
- Procurement workflow reduced from 3-4 hours per week to 30 minutes per week
The results after 12 months
Annual peptide spend
- Before: USD 220,000 at list price
- After: USD 158,000 under supply contract (28% reduction)
Tier pricing contribution
- 20% off list price on top 5 SKUs (forecast commitment)
- 5% off bulk packaging optimization (quarterly combined orders)
- 3% effective savings from procurement overhead reduction
Procurement time
- Before: 3-4 hours per week
- After: 30 minutes per week (86% reduction)
Grant delay incidents
- Before: 3 grant milestones delayed by peptide procurement issues in the prior year
- After: 0 grant milestones delayed by peptide procurement in the first contract year
COA acceptance rate
- Before: 75% first-attempt acceptance
- After: 99% first-attempt acceptance
Key lessons for institutional GLP-1 programs
Lesson 1: The forecast is the negotiation lever The single most powerful change was committing to a 12-month forecast. Once the suppliers saw committed volume, the pricing conversation changed from catalog to contract. The program paid 20% less for exactly the same material.
Lesson 2: Auto-release eliminates the administrative burden Monthly auto-release converted 3-4 hours per week of manual ordering into 30 minutes per week of COA verification and filing. The grant's research assistant time was recaptured for actual research.
Lesson 3: A quality agreement protects grant milestones Grant-funded research has hard milestone dates. A quality agreement with a deviation handling clause — 24-hour notification, 5-day investigation, replacement lot within 14-21 days — means a failed lot does not become a missed milestone.
How to structure your own institutional supply contract
Three steps:
- **Compile 12 months of PO data** — compound, supplier, volume, spend, delay incidents
- **Identify your top 5 SKUs** — these are your auto-release candidates
- **Get tier-priced RFQ responses with a forecast** — commit to a 12-month forecast and watch the price and lead time improve
ZePeptide supports institutional GLP-1 research programs with supply contracts, tier pricing, and monthly auto-release. Talk to our academic team to scope a contract.
ZePeptide content is for lawful laboratory and in-vitro research sourcing. Products are not supplied for human or veterinary use.